重症医学科血小板减少的常见原因及病因分析(3)
[6] 鲁成龙.重症感染合并血小板减少的中西医结合研究与诊治进展[J].中国医学创新，2018，15(29)：145-148.
[7] Qin Wu， Jianan Ren， Gefei Wang，et al. Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients： A Retrospective Study[J]. Clinical & Applied Thrombosis/hemostasis Official Journal of the International Academy of Clinical & Applied Thrombosis/hemostasis， 2015， 23(1)：84.
[8] Florry E， van den Boogaard，Marcel Schouten，et al.Thromboc ytopenia impairs host defense during murine Streptococcus pneumoniae pneumonia[J].Critical care medicine，2015，43(3)：75-83.
[9] 李金，吳凯乐.临床常见血小板减少影响因素的研究进展[J].中国当代医药，2018，25(32)：29-31，43.
[10] Ian W. Flinn，Jack Erter，Davey B. Daniel， et al.Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy[J].The Oncologist，2019，24(8)：1035-623.
[11] Miguel Martín，Noelia Martínez，Manuel Ramos，et al.Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05)：A Randomized， Noninferiority Phase II Trial With a Pharmacogenetic Analysis[J].The Oncologist，2015，20(2)：111-112.
[12] 韩燕燕.临床常见血小板减少的原因分析[J].泰山医学院学报，2016，37(12)：1342-1345.
(收稿日期：2020-04-07), http://www.100md.com(林明相)
[7] Qin Wu， Jianan Ren， Gefei Wang，et al. Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients： A Retrospective Study[J]. Clinical & Applied Thrombosis/hemostasis Official Journal of the International Academy of Clinical & Applied Thrombosis/hemostasis， 2015， 23(1)：84.
[8] Florry E， van den Boogaard，Marcel Schouten，et al.Thromboc ytopenia impairs host defense during murine Streptococcus pneumoniae pneumonia[J].Critical care medicine，2015，43(3)：75-83.
[9] 李金，吳凯乐.临床常见血小板减少影响因素的研究进展[J].中国当代医药，2018，25(32)：29-31，43.
[10] Ian W. Flinn，Jack Erter，Davey B. Daniel， et al.Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy[J].The Oncologist，2019，24(8)：1035-623.
[11] Miguel Martín，Noelia Martínez，Manuel Ramos，et al.Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05)：A Randomized， Noninferiority Phase II Trial With a Pharmacogenetic Analysis[J].The Oncologist，2015，20(2)：111-112.
[12] 韩燕燕.临床常见血小板减少的原因分析[J].泰山医学院学报，2016，37(12)：1342-1345.
(收稿日期：2020-04-07), http://www.100md.com(林明相)